The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients

Psychiatric Bulletin

Volumn 26, Issue 11, 2002, Pages 411-414

  Lelliott, Paul ^a   Paton, Carol ^a   Harrington, Maria ^a   Konsolaki, Maria ^a   Sensky, Tom ^a   Okocha, Chike ^a  

^a ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DELUSIONAL DISORDER; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG MEGADOSE; ETHNOLOGY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LAW; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOOD DISORDER; NEUROSIS; ORGANIC PSYCHOSYNDROME; PERSONALITY DISORDER; POLYPHARMACY; POPULATION RESEARCH; PRESCRIPTION; PROBABILITY; PSYCHIATRIC DEPARTMENT; REHABILITATION CENTER; SCHIZOPHRENIA; SEX DIFFERENCE; SOMATOFORM DISORDER; STATISTICAL ANALYSIS; VARIANCE;

EID: 0036849039     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.26.11.411     Document Type: Article

References (11)

1. Benson, P. R. (1983) Factors associated with antipsychotic drug prescribing by southern psychiatrists. Medical Care, 21, 639-654.
2. Bhui, K. (1998) London's Ethnic Minorities and the Provision of Mental Health Services. In London's Mental Health: The Report to the London King's Fund Commission (eds S. Johnson, R. Ramsay, G. Thornicroft, et al), pp. 143-166. London: King's Fund.
3. British Medical Association & Royal Pharmaceutical Society OF Great Britain (1999) British National Formulary. London & Wallingford: BMJ Books & Pharmaceutical Press.
4. Chaplin, R. & McGuigan, S. (1996) Antipsyhotic dose: from research to clinical practice. Psychiatric Bulletin, 20, 452-454.
5. Harrington, M., Lelliott, P., Paton, C. et al (2002a) The results of a multicentre audit of the prescribing of antipsychotic drugs for in-patients in the UK. Psychiatric Bulletin, 26, 414-418.
6. Harrington, M., Lelliot, P., Paton, C., et al (2002b) Variation between services in polypharmacy and high dose of antipsychotic drugs prescribed for in-patients. Psychiatric Bulletin, 26, 418-420.
7. Muscettola, G., Bollini, P. & Pampallona, S. (1991) Pattern of neuroleptic drug use in Italian Mental Health Services. Annals of Pharmacotherapy, 25, 296-301.
8. Tibaldi, G., Muizza, C., Bollini, P., et al (1997) Utilization of neuroleptic drugs in Italian Mental Health Services: A survey in Piedmont. Psychiatric Services, 48, 213-217.
9. Walkup, J. T., McAlpine, M. A., Olfson, M., et al (2000) Patients with schizophrenia at risk for excessive antipsychotic dosing. Journal of Clinical Psychiatry, 61, 344-348.
10. Wilkie, A., Preston, N. & Wesby, R. (2001) High dose neuroleptics - who gives them and why? Psychiatric Bulletin, 25, 179-183.
11. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines. Geneva: WHO.